Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide

NCT02991456 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Chemo-radiation Induced Nausea and Vomiting

Interventions

DRUG: Rolapitant
DRUG: Ondansetron

Sponsor

Duke University